Zacks has CXR as BUY with $58 target Everywhere I look, I only see positive from this low $41 CDN / $31 USD Concordina price.
CXR on the TSE and CXRX on Nasdaq
Zacks raised shares of Concordia Healthcare from a “hold” rating to a “buy” rating and set a $44.00 US price objective. That's $58 Canadian.
ALL analysts REVISED objectives shows how undervalued this stock is. Buy and don't worry about the daily price fluctuations. It seems that all investors and traders are all very nervous which what make me excited in a good way! I've been buying and my average price is less that $30 CDN and I'm not letting go a single share at these prices. Even as an very aggressive short term investor!
Cool headed invetors need to remember the very strong fundamentals on this company.
The bashers on this board all use extreme social mental manipulation using old tricks like focussing on the few straws they can find. You need to step back, look at the WHOLE COMPANY and what educated, intelligent, rational people and analysts are saying!
These bashers come from the Ventures world and have moved up from pumping/bashing worthless stocks and are using the same techniques to bash great companies on these large cap stocks now! Incredible!
Let's see of the market can leave emotions aside this week. One thing for sure it this volatility is great for gains. I've make a fortune on energy and resources last monnth and October is Health Month for this value investor with years of experience. Made a fortune on BCE (Bell) when it was in the dumps (at lows) and sold it when everyone was way too positive. Being a contrarian and buying at lows is what has made me money.
Follow the hype, lose your money. Follow the mindless bashers and lose your money!